Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiovascular Risk Reports
Erschienen in: Current Cardiovascular Risk Reports 3/2014

01.03.2014 | Lipids (J Ordovas, L Parnell, Section Editors)

Review Article: An Adipocentric View of the Metabolic Syndrome and Cardiovascular Disease

verfasst von: Michael Conall Dennedy, Antonio Vidal-Puig

Erschienen in: Current Cardiovascular Risk Reports | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Dysfunctional adipose tissue impairs whole body lipid buffering, influencing the storage of lipids as well as their use as an energy source. Ectopic deposition of lipids within metabolic tissues arises as a result of adipose tissue dysfunction and the ensuing systemic lipotoxicity explains much of the pathogenesis underlying insulin resistance and cardiometabolic disease. Adipose tissue dysfunction appears to be a multifactorial, maladaptive response to a lipid-rich, high calorie diet which involves the interplay between adipocyte precursors, adipocytes, immune cells, lipoprotein carriers and metabolically active tissues. Understanding these interactions and unravelling the adipocentric nature of cardiometabolic complications relating to obesity is a major priority towards addressing the worldwide obesity pandemic and its costly complications.
Literatur
1.
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA J Am Med Assoc. 2010;303(3):235–41.CrossRef
2.
Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA J Am Med Assoc. 2010;303(3):242–9.CrossRef
3.
4.
Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome–an allostatic perspective. Biochim Biophys Acta. 2010;1801(3):338–49.PubMedCrossRef
5.
Nishimura S, Manabe I, Nagasaki M, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes. 2007;56(6):1517–26.PubMedCrossRef
6.
Greenberg AS, Coleman RA, Kraemer FB, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011;121(6):2102–10.PubMedCentralPubMedCrossRef
7.
8.
9.••
McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes. 2011;60(1):47–55. This study highlights an elaborate set of whole body physiological experiments in lean and obese men. The authors identify the maladaptive response and impaired storage of dietary fatty acids induced by enlargement of adipose tissue mass. PubMedCentralPubMedCrossRef
10.
11.
Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783–7.PubMedCrossRef
12.
McQuaid SE, Humphreys SM, Hodson L, Fielding BA, Karpe F, Frayn KN. Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes. 2010;59(10):2465–73.PubMedCentralPubMedCrossRef
13.
Langin D. In and out: adipose tissue lipid turnover in obesity and dyslipidemia. Cell Metab. 2011;14(5):569–70.PubMedCrossRef
14.
Arner P, Bernard S, Salehpour M, et al. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature. 2011;478(7367):110–3.PubMedCentralPubMedCrossRef
15.
Parker VE, Savage DB, O’Rahilly S, Semple RK. Mechanistic insights into insulin resistance in the genetic era. Diabet Med J Br Diabet Assoc. 2011;28(12):1476–86.CrossRef
16.••
Gandotra S, Le Dour C, Bottomley W, et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364(8):740–8. Gandotra et al. present an interesting human study which identifies two different heterozygous PLIN1 mutatiions manifesting as a deficiency of the lipid droplet assoicated protein, perilipin which caused partial lipodystrophy. This manifested as dyslipidaemia, hepatic steatosis and insulin resistance. Hence the imprtance of appropriate lipid storage in the pathogenesis of the metabolis syndrome is again highlighted. PubMedCentralPubMedCrossRef
17.
Rubio-Cabezas O, Puri V, Murano I, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med. 2009;1(5):280–7.PubMedCentralPubMedCrossRef
18.
Savage DB, Tan GD, Acerini CL, et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 2003;52(4):910–7.PubMedCrossRef
19.
Veilleux A, Caron-Jobin M, Noel S, Laberge PY, Tchernof A. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes. 2011;60(5):1504–11.PubMedCentralPubMedCrossRef
20.
Leonhardt W, Haller H, Hanefeld M. The adipocyte volume in human adipose tissue: II. Observations in diabetes mellitus, primary hyperlipoproteinemia and weight reduction. Int J Obes. 1978;2(4):429–39.PubMed
21.
Imbeault P, Lemieux S, Prud’homme D, et al. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism. 1999;48(3):355–62.PubMedCrossRef
22.
Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012;81(1):715–36.PubMedCrossRef
23.
24.
Savage DB. PPAR gamma as a metabolic regulator: insights from genomics and pharmacology. Expert Rev Mol Med. 2005;7(1):1–16.PubMedCrossRef
25.
Oñate B, Vilahur G, Camino Lopez S, et al. Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype. BMC Genomics. 2013;14(1):625–637.
26.
Jung C, Fischer N, Fritzenwanger M, Pernow J, Brehm BR, Figulla HR. Association of waist circumference, traditional cardiovascular risk factors, and stromal-derived factor-1 in adolescents. Pediatr Diabetes. 2009;10(5):329–35.PubMedCrossRef
27.
28.
Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333–8.PubMedCentralPubMedCrossRef
29.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–808.PubMedCentralPubMedCrossRef
30.
Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation–mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32(8):1771–6.PubMedCrossRef
31.
Lee YH, Petkova AP, Granneman JG. Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab. 2013;18(3):355–67.PubMedCrossRef
32.
Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE. 2011;6(4):e18284.PubMedCentralPubMedCrossRef
33.
Desai M, Beall M, Ross MG. Developmental origins of obesity: programmed adipogenesis. Curr Diabetes Rep. 2012;13(1):27–33.CrossRef
34.
Lagathu C, Christodoulides C, Virtue S, et al. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network. Diabetes. 2009;58(3):609–19.PubMedCentralPubMedCrossRef
35.
Puri V, Ranjit S, Konda S, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A. 2008;105(22):7833–8.PubMedCentralPubMedCrossRef
36.
Liu M, Guo L, Liu Y, et al. Adipose stromal-vascular fraction-derived paracrine factors regulate adipogenesis. Mol Cell Biochem. 2013;385(1–2):115–23.CrossRef
37.
Harman-Boehm I, Bluher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab. 2007;92(6):2240–7.PubMedCrossRef
38.
Herold C, Rennekampff HO, Engeli S. Apoptotic pathways in adipose tissue. Apoptosis. 2013;18(8):911–6.PubMedCrossRef
39.
40.
Kallen CJH, Greevenbroek MMJ, Stehouwer CDA, Schalkwijk CG. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver? Apoptosis. 2009;14(12):1424–34.PubMedCentralPubMedCrossRef
41.
Bekhite MM, Finkensieper A, Rebhan J, et al. Hypoxia, leptin and VEGF stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells. Stem Cells Dev 2013.
42.
Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc. 2009;68(4):370–7.PubMedCrossRef
43.
Khan T, Muise ES, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009;29(6):1575–91.PubMedCentralPubMedCrossRef
44.
45.
Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299(6):E1016–27.PubMedCentralPubMedCrossRef
46.
Naour N, Rouault C, Fellahi S, et al. Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation. J Clin Endocrinol Metab. 2010;95(4):1861–8.PubMedCrossRef
47.
Goossens GH, Bizzarri A, Venteclef N, et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation. 2011;124(1):67–76.PubMedCrossRef
48.
Qian H, Hausman DB, Compton MM, et al. TNFalpha induces and insulin inhibits caspase 3-dependent adipocyte apoptosis. Biochem Biophys Res Commun. 2001;284(5):1176–83.PubMedCrossRef
49.
Votruba SB, Mattison RS, Dumesic DA, Koutsari C, Jensen MD. Meal fatty acid uptake in visceral fat in women. Diabetes. 2007;56(10):2589–97.PubMedCrossRef
50.
Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107.PubMedCrossRef
51.
52.
Prieur X, Mok CY, Velagapudi VR, et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011;60(3):797–809.PubMedCentralPubMedCrossRef
53.
Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116(1):115–24.PubMedCentralPubMedCrossRef
54.
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–84.PubMedCentralPubMedCrossRef
55.
Shapiro H, Pecht T, Shaco-Levy R, et al. Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab. 2013;98(3):1173–81.PubMedCrossRef
56.
Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117(1):195–205.PubMedCentralPubMedCrossRef
57.
58.
Tsou CL, Peters W, Si Y, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007;117(4):902–9.PubMedCentralPubMedCrossRef
59.
Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002;23(6):301–4.PubMedCrossRef
60.
Maloney E, Sweet IR, Hockenbery DM, et al. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol. 2009;29(9):1370–5.PubMedCentralPubMedCrossRef
61.
Prieur X, Roszer T, Ricote M. Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta. 2010;1801(3):327–37.PubMedCrossRef
62.
Shaikh SR, Mitchell D, Carroll E, Li M, Schneck J, Edidin M. Differential effects of a saturated and a monounsaturated fatty acid on MHC class I antigen presentation. Scand J Immunol. 2008;68(1):30–42.PubMedCentralPubMedCrossRef
63.
Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE. Diabetes and apoptosis: lipotoxicity. Apoptosis. 2009;14(12):1484–95.PubMedCrossRef
64.
Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab. 2001;86(12):5755–61.PubMedCrossRef
65.
Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL. Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001;86(11):5412–9.PubMedCrossRef
66.
Fischer J, Lefevre C, Morava E, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007;39(1):28–30.PubMedCrossRef
67.
Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006;45(1):42–72.PubMedCrossRef
68.
Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117(6):1679–89.PubMedCentralPubMedCrossRef
69.
Lee H-Y, Després J-P, Koh KK. Perivascular adipose tissue in the pathogenesis of cardiovascular disease. Atherosclerosis. 2013;230(2):177–84.PubMedCrossRef
70.
Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–17.PubMedCentralPubMedCrossRef
71.
Ouellet V, Labbe SM, Blondin DP, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest. 2012;122(2):545–52.PubMedCentralPubMedCrossRef
72.
73.
74.
Whittle AJ, Carobbio S, Martins L, et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell. 2012;149(4):871–85.PubMedCentralPubMedCrossRef
75.
Whittle A, Relat-Pardo J, Vidal-Puig A. Pharmacological strategies for targeting BAT thermogenesis. Trends Pharmacol Sci. 2013;34(6):347–55.PubMedCrossRef
76.
Villarroya F, Vidal-Puig A. Beyond the sympathetic tone: the new brown fat activators. Cell Metab. 2013;17(5):638–43.PubMedCrossRef
77.
Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.PubMedCentralPubMedCrossRef
78.
Frontini A, Vitali A, Perugini J, et al. White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. Biochim Biophys Acta. 2013;1831(5):950–9.PubMedCrossRef
79.
Bartelt A, Bruns OT, Reimer R, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200–5.PubMedCrossRef
80.
Dong M, Yang X, Lim S, et al. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 2013;18(1):118–29.PubMedCentralPubMedCrossRef
81.
Barneda D, Frontini A, Cinti S, Christian M. Dynamic changes in lipid droplet-associated proteins in the “browning” of white adipose tissues. Biochim Biophys Acta. 2013;1831(5):924–33.PubMedCrossRef
Metadaten
Titel
Review Article: An Adipocentric View of the Metabolic Syndrome and Cardiovascular Disease
verfasst von
Michael Conall Dennedy
Antonio Vidal-Puig
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Current Cardiovascular Risk Reports / Ausgabe 3/2014
Print ISSN: 1932-9520
Elektronische ISSN: 1932-9563
DOI
https://doi.org/10.1007/s12170-014-0379-4

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

24.04.2024 | Adipositas | Nachrichten

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 | ACC 2024 | Nachrichten

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen